The Evolving Patentability of Genetic Material in Australia post-Myriad
A number of decisions by the Australian Patent Office following the 2015 “Myriad” decision have provided further clarity in regard to what genetic material may be patentable under Australian...
A number of decisions by the Australian Patent Office following the 2015 “Myriad” decision have provided further clarity in...
Read More
How to design around a patent to avoid infringement
Sometimes inventors come up with an idea for a new product. However, much to their surprise, they discover that someone else already has a patent covering it.
Sometimes inventors come up with an idea for a new product. However, much to their surprise, they discover that...
Read More
China revises guidelines for patent examination
China’s State Intellectual Property Office (SIPO) recently released amendments to its Guidelines for Patent Examination (2010), which will take effect from 1 April 2017.
China’s State Intellectual Property Office (SIPO) recently released amendments to its Guidelines for Patent Examination (2010), which will take...
Read More
Routine omnibus – not routine anymore in the UK
From the 6 April 2017, the United Kingdom Intellectual Property Office (“UKIPO”) will only allow omnibus claims in United Kingdom (UK) patent applications and European patent application designating Great Britain (GB) in...
From the 6 April 2017, the United Kingdom Intellectual Property Office (“UKIPO”) will only allow omnibus claims in United Kingdom (UK)...
Read More
Contributory Infringement: what is it and are you and your invention at risk?
It is a patent owner’s responsibility to enforce their patent rights. This includes detecting any infringement of their patent and taking appropriate action against infringers. Most patent owners are aware...
It is a patent owner’s responsibility to enforce their patent rights. This includes detecting any infringement of their patent...
Read More
Poisonous Priority: Is it a problem?
The European Patent Office (EPO) recently issued its reasoned decision clarifying the EPO’s stance regarding partial priority (sometimes called multiple priorities).  But what is the relationship between poisonous priority...
The European Patent Office (EPO) recently issued its reasoned decision clarifying the EPO’s stance regarding partial priority (sometimes called...
Read More
How to avoid being poisoned by your own patent application
As most patent applicants know, the patentability of an invention is determined by comparing the invention to the pool of public knowledge that existed before the date the application...
As most patent applicants know, the patentability of an invention is determined by comparing the invention to the pool...
Read More
The importance of Swiss-style claims in Australia
The Federal Court has recently issued a decision that highlights the importance of including Swiss-style claims in Australian pharmaceutical patents. As reported previously, the Federal Court (Nicholas J) confirmed in Apotex Pty...
The Federal Court has recently issued a decision that highlights the importance of including Swiss-style claims in Australian pharmaceutical...
Read More
Excess claim fees in Singapore to take effect from 1 April 2017
We recently reported on the Intellectual Property Office of Singapore’s (IPOS) announcement in regard to lowering fees for Intellectual Property Protection from 1 April 2017. As part of this,...
We recently reported on the Intellectual Property Office of Singapore’s (IPOS) announcement in regard to lowering fees for Intellectual...
Read More